RDY
Dr. Reddy's Laboratories Ltd. Earnings
$13.47
Earnings Summary
Revenue | $87268Mn |
Net Profits | $12098Mn |
Net Profit Margins | 13.86% |
Dr. Reddy's Laboratories Ltd.’s revenue jumped 4.41% since last year same period to $87268Mn in the Q4 2025. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -0.89% fall in its revenue since last 3-months.
Dr. Reddy's Laboratories Ltd.’s net profit fell -14.4% since last year same period to $12098Mn in the Q4 2025. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -15.82% fall in its net profits since last 3-months.
Dr. Reddy's Laboratories Ltd.’s net profit margin fell -18.01% since last year same period to 13.86% in the Q4 2025. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -15.07% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.16 |
EPS Estimate Current Year | 0.16 |
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current quarter stand at 0.16 - a 1.63% jump from last quarter’s estimates.
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current year stand at 0.16.
Key Ratios
Earning Per Share (EPS) | 0 |
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Dr. Reddy's Laboratories Ltd. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-08 | 0.16 | 0 | -100% |
